ORUM (KQ:475830) — Market Cap & Net Worth
Market Cap & Net Worth: ORUM (475830)
ORUM (KQ:475830) has a market capitalization of $424.14K (₩625.87 Million) as of June 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #30894 globally and #2045 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ORUM's stock price ₩64100.00 by its total outstanding shares 9764 (9.76K). Review ORUM (475830) financial obligations to assess the company's total debt and financial obligations.
ORUM Market Cap History: 2025 to 2026
ORUM's market capitalization history from 2025 to 2026. Data shows growth from $794.03K to $424.14K (0.00% CAGR).
ORUM Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ORUM's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 475830 by Market Capitalization
Companies near ORUM in the global market cap rankings as of June 19, 2026.
Key companies related to ORUM by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.20 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €762.80 |
ORUM Historical Marketcap From 2025 to 2026
Between 2025 and today, ORUM's market cap moved from $794.03K to $ 424.14K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩424.14K | -46.58% |
| 2025 | ₩794.03K | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of ORUM was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $424.14K USD |
| MoneyControl | $424.14K USD |
| MarketWatch | $424.14K USD |
| marketcap.company | $424.14K USD |
| Reuters | $424.14K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ORUM
Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases. The company develops BMS-986497 (ORM-6151), which is in phase 1 clinical trial to treat acuta myeloid leukemia and high-risk myelodysplastic syndromes; ORM-1153, which is in preclinical trial to treat acuta myeloid leukemia and heme-onc; and ORM-1023, wh… Read more